Form 4: Guardant Health's Co-CEO Helmy Eltoukhy Reports Stock Transactions
SEC Form 4 Filing
Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reported the vesting of restricted stock units and associated tax withholding, resulting in changes to his beneficial ownership of company stock.
Summary
- On September 30, 2024, Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, engaged in transactions involving the company's stock.
- He acquired 11,461 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 5,809 shares were withheld by the company to cover tax obligations related to the vesting of these units at a price of $22.94.
- Following these transactions, Eltoukhy's directly held beneficial ownership of common stock is 2,304,266 shares.
- He also holds 11,462 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions, with neutral sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of stock transactions (vesting of restricted stock units and tax withholding). |
| 10/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.